Latest Breaking News On - Circulatory support program - Page 3 : comparemela.com

Hemostemix Inc : Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation

Calgary, Alberta (Newsfile Corp. - January 19, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has received a $250,000 Letter of Commitment

Stanford universityUnited statesThomas smeenkRenzo cecereNadia giannettiJulie quennevilleHeart transplantation programTransplantation at stanford universityMyocardial regeneration laboratoryRegulation service providerPrincipal investigator of the research instituteCirculatory support programWorld economic forum technology pioneer awardHemostemix incBig campaignMcgill university

Hemostemix Inc : Hemostemix Announces Dr Giannetti and Dr Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials

Calgary, Alberta (Newsfile Corp. - October 26, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce Dr. Giannetti and Dr. Cecere as Co-Lead

Thomas smeenkHeart transplantation programMyocardial regeneration laboratoryRegulation service providerPrincipal investigator of the research instituteCirculatory support programWorld economic forum technology pioneer awardHemostemix incMcgill universityAlberta newsfile corpVenture exchangeDepartment of medicineMcgill university health centreCecere as coCo lead medical consultantsCardiovascular medicine

Hemostemix Announces Dr Giannetti and Dr Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials

Hemostemix Announces Dr Giannetti and Dr Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas smeenkHeart transplantation programMyocardial regeneration laboratoryRegulation service providerPrincipal investigator of the research instituteCirculatory support programWorld economic forum technology pioneer awardHemostemix incMcgill universityAlberta newsfile corpVenture exchangeDepartment of medicineMcgill university health centreCecere as coCo lead medical consultantsCardiovascular medicine

Hemostemix Announces the Appointment of Dr Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

Hemostemix Announces the Appointment of Dr Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas smeenkRenzo cecereHeart transplantation programMyocardial regeneration laboratoryRegulation service providerPrincipal investigator of the research instituteCirculatory support programWorld economic forum technology pioneer awardHemostemix incMcgill universityAlberta newsfile corpVenture exchangeScientific advisoryMcgill university chiefCardiac surgerySurgical director

Hemostemix Inc : Hemostemix Announces the Appointment of Dr Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

Calgary, Alberta (Newsfile Corp. - September 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Renzo Cecere, MD, FRCSC

Thomas smeenkRenzo cecereHeart transplantation programMyocardial regeneration laboratoryRegulation service providerPrincipal investigator of the research instituteCirculatory support programWorld economic forum technology pioneer awardHemostemix incMcgill universityAlberta newsfile corpVenture exchangeScientific advisoryMcgill university chiefCardiac surgerySurgical director